Grey Street Capital »

Teva Pharmaceutical Industries shares owned by Grey Street Capital

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Grey Street Capital from 13F filings

Historical chart of Grey Street Capital investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Grey Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Grey Street Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 131k 14.11
2023-12-31 $1.4M 131k 10.44
2023-09-30 $1.3M 131k 10.20
2023-06-30 $986k 131k 7.53
2023-03-31 $1.2M 131k 8.85

More positions owned by Grey Street Capital

NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Accenture Plc Ireland Shs Class A (ACN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Crowdstrike Hldgs Cl A (CRWD)
Adobe Systems Incorporated (ADBE)
Goldman Sachs (GS)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Grey Street Capital

Top funds holding Teva Pharmaceutical Industries

BlackRock
BlackRock
Ion Asset Management
Clal Insurance Enterprises Holdings
Exor Investments
Migdal Insurance & Financial Holdings
Phoenix Holdings
Slate Path Capital
State Street Corporation
Rubric Capital Management
Morgan Stanley
Millennium Management
PointState Capital
Glenview Captal Management
Geode Capital Management

View all funds holding Teva Pharmaceutical Industries